Back to UBS Group AG UBS Group AG

BDMDBDMD
7 quarters

Position history for UBS Group AGUBS Group AG's holdings in BAIRD MED INVT HLDGS LTD

Yes. Ubs holds 58,687 shares of BDMD (Baird Med Investment), worth $67,490, as of its Q2 2026 13F filing. It reduced the position by 9,176 shares (-13.5%) from Q1 2026. Ubs has held BDMD since Q4 2024, across 7 quarterly 13F filings.

Current Value

$67,490

Current Shares

58,687

Total Value Change

+$56,804

Total Shares Change

+57,281

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
58,687
-13.5%
$67,4900.0%$1.15
0
2026-Q1
Increased
67,863
+100.2%
$133,0120.0%$2.49
24
2025-Q4
Decreased
33,906
-48.5%
$46,1120.0%$1.37
0
2025-Q3
Decreased
65,818
-28.0%
$139,5340.0%$2.29
0
2025-Q2
Increased
91,449
+60.6%
$335,1600.0%$3.90
34
2025-Q1
Increased
56,937
+3949.6%
$296,6420.0%$5.51
38
2024-Q4
New
1,406
-
$10,6860.0%$1.05
26

Other major holders of BDMD: NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, TWO SIGMA INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used